"Parkinson Vaccination" Gives Hope for Those Affected

Kronen Zeitung

Right

Factuality

Ownership

Is there hope soon for people with Parkinson's disease? Results of a so-called Phase II study with local involvement in an antibody have shown that it can slow down the course of the disease, according to the journal "The Lancet". In Europe and the USA, an approval study (Phase III) for the first disease-modifying therapy of Parkinson's disease with the active substance prasinezumab is being conducted. The Medical University of Innsbruck spoke i…

Kurier

Lean Right

Factuality

Ownership

Studies are still underway on an antibody that could slow down the course of the disease.

vienna.at

Factuality

Ownership

A Phase III clinical trial for the first disease-modifying therapy for Parkinson's disease, using the drug prasinezumab, is underway in Europe and the US. The Medical University of Innsbruck described it as a passive Parkinson's vaccination in a press release on Monday. According to the researchers, results from a Phase II trial with Austrian participation showed promising signs for recognizing the drug's efficacy. These results have now been pu…